Pneumococcal Vaccination in Europe: Schedule Adherence

被引:16
|
作者
Gervaix, Alain [1 ]
Ansaldi, Filippo [2 ,3 ]
Brito-Avo, Antonio [4 ]
Azzari, Chiara [5 ,6 ]
Knuf, Markus [7 ,8 ]
Martinon-Torres, Federico [9 ,10 ]
Tuerlinckx, David [11 ]
Htar, Myint Tin Tin [12 ]
Syrogiannopoulos, George A. [13 ]
机构
[1] Univ Childrens Hosp, Paediat Emergency Med Serv, Geneva, Switzerland
[2] Univ Genoa, Genoa, Italy
[3] IRCCS AOU San Martino IST, Genoa, Italy
[4] Pediat Clin, Lisbon, Portugal
[5] Univ Florence, Florence, Italy
[6] Anna Meyer Childrens Hosp, Florence, Italy
[7] Dr Horst Schmidt Kliniken, Klinikum Landeshauptstadt Wiesbaden HSK, Wiesbaden, Germany
[8] Univ Med Mainz, Mainz, Germany
[9] Hosp Clin Univ Santiago de Compostela, Santiago, Spain
[10] Inst Invest Sanitaria Santiago, Genet Vaccines Infect & Pediat Res Grp GENVIP, Santiago, Spain
[11] Catholic Univ Louvain, Ctr Hosp Univ Mont Godinne, Dept Pediat, Yvoir, Belgium
[12] Pfizer Inc, Paris, France
[13] Univ Thessaly, Dept Pediat, Sch Hlth Sci, Fac Med,Gen Univ Hosp Larissa,Biopolis, Larisa, Greece
关键词
pneumococcal conjugate vaccine; Streptococcus pneumoniae; vaccination schedule adherence; vaccine uptake; CONJUGATE VACCINE; PNEUMONIA; CHILDREN; TRENDS; EFFICACY; COVERAGE; ENGLAND; DISEASE; IMPACT;
D O I
10.1016/j.clinthera.2014.03.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the primary PCV and booster series) in different European countries. We found that adherence with the PCV schedule was lower than that for diphtheria-tetanus-acellular pertussis (DTaP) and that higher adherence was observed in countries where PCV vaccination is recommended and funded. Adherence with the booster dose is often lower than that with the primary series completion, and it is often given after the recommended age. These data highlight the need to encourage timely vaccination of children with PCV, in line with local immunization schedules. There is no single solution to improve adherence; actions need to be tailored to the context of individual countries through initiatives at the national, regional, and local levels and should target different stakeholders. (C) 2014 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:802 / 812
页数:11
相关论文
共 50 条
  • [1] Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus
    Hadjipanayis, Adamos
    Efstathiou, Elisavet
    Michaelidou, Kyriaki
    Papaevangelou, Vasiliki
    VACCINE, 2018, 36 (38) : 5685 - 5691
  • [2] Constrained Optimization for Pneumococcal Vaccination in Brazil
    Olbrecht, Jan
    Gomez, Jorge A.
    Van Bellinghen, Laure-Anne
    Van Vlaenderen, Ilse
    Standaert, Baudouin
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 26 : 40 - 49
  • [3] Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule
    Vestrheim, Didrik F.
    Hoiby, E. Arne
    Bergsaker, Marianne R.
    Ronning, Karin
    Aaberge, Ingeborg S.
    Caugant, Dominique A.
    VACCINE, 2010, 28 (10) : 2214 - 2221
  • [4] Resurgence of pneumococcal meningitis in Europe and Northern America
    Koelman, D. L. H.
    Brouwer, M. C.
    van de Beek, D.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (02) : 199 - 204
  • [5] Cost-effectiveness of universal pneumococcal vaccination in Uruguay
    Giachetto Larraz, Gustavo
    Telechea Ortiz, Hector
    Speranza Mourine, Noelia
    Giglio, Norberto
    Cane, Alejandro
    Pirez Garcia, Maria C.
    Lucas Paiva, Liriana
    Pallarese Barrios, Carla
    Gesuele Ruggiero, Juan
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 28 (02): : 92 - 99
  • [6] Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review
    Flem, Elmira
    Mouawad, Celine
    Palmu, Arto A.
    Platt, Heather
    Johnson, Kelly D.
    Mcintosh, E. David
    Abadi, Jacobo
    Buchwald, Ulrike K.
    Feemster, Kristen
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 997 - 1010
  • [7] Pneumococcal vaccination
    Pletz, Mathias W.
    Bahrs, Christina
    INTERNIST, 2021, 62 (08): : 807 - 815
  • [8] Cost-effectiveness analysis of pneumococcal vaccination for infants in China
    Maurer, Kristin A.
    Chen, Huey-Fen
    Wagner, Abram L.
    Hegde, Sonia T.
    Patel, Tejasi
    Boulton, Matthew L.
    Hutton, David W.
    VACCINE, 2016, 34 (50) : 6343 - 6349
  • [9] Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe
    Fedson, David S.
    Nicolas-Spony, Laurence
    Klemets, Peter
    van der Linden, Mark
    Marques, Agostinho
    Salleras, Luis
    Samson, Sandrine I.
    EXPERT REVIEW OF VACCINES, 2011, 10 (08) : 1143 - 1167
  • [10] Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial
    Temple, Beth
    Nguyen Trong Toan
    Uyen, Doan Y.
    Balloch, Anne
    Bright, Kathryn
    Cheung, Yin Bun
    Licciardi, Paul
    Cattram Duong Nguyen
    Nguyen Thi Minh Phuong
    Satzke, Catherine
    Smith-Vaughan, Heidi
    Thi Que Huong Vu
    Tran Ngoc Huu
    Mulhollan, Edward Kim
    BMJ OPEN, 2018, 8 (06):